BNP Paribas Arbitrage SA trimmed its holdings in Masimo Corporation (NASDAQ:MASI) by 19.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 26,365 shares of the medical equipment provider’s stock after selling 6,514 shares during the period. BNP Paribas Arbitrage SA owned 0.05% of Masimo Corporation worth $2,282,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of MASI. BlackRock Inc. grew its stake in Masimo Corporation by 7.5% in the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after acquiring an additional 550,995 shares during the last quarter. Koch Industries Inc. boosted its stake in shares of Masimo Corporation by 5,053.7% during the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock worth $439,000 after purchasing an additional 435,325 shares during the last quarter. Acadian Asset Management LLC boosted its stake in shares of Masimo Corporation by 28.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after purchasing an additional 392,410 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Masimo Corporation by 76.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock worth $73,191,000 after purchasing an additional 347,360 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Masimo Corporation by 6.9% during the 2nd quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock worth $450,036,000 after purchasing an additional 318,060 shares during the last quarter. 84.70% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/11/23/bnp-paribas-arbitrage-sa-lowers-position-in-masimo-corporation-masi.html.

Shares of Masimo Corporation (NASDAQ MASI) opened at $87.84 on Thursday. The stock has a market cap of $4,577.03, a P/E ratio of 33.94, a PEG ratio of 2.98 and a beta of 0.75. Masimo Corporation has a 12 month low of $60.31 and a 12 month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.17. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The business had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. During the same quarter last year, the company earned $0.52 earnings per share. The business’s quarterly revenue was up 15.6% compared to the same quarter last year. analysts expect that Masimo Corporation will post 2.95 earnings per share for the current fiscal year.

In other Masimo Corporation news, Director Steven Barker sold 10,000 shares of Masimo Corporation stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the completion of the transaction, the director now owns 73,249 shares of the company’s stock, valued at $6,592,410. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Yongsam Lee sold 5,000 shares of Masimo Corporation stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00. Following the completion of the transaction, the executive vice president now directly owns 74,000 shares of the company’s stock, valued at approximately $6,651,860. The disclosure for this sale can be found here. Insiders have sold 28,976 shares of company stock valued at $2,599,324 in the last three months. Corporate insiders own 16.60% of the company’s stock.

Several research firms have issued reports on MASI. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a research report on Thursday, November 2nd. Stifel Nicolaus reissued a “buy” rating and issued a $108.00 target price (up from $105.00) on shares of Masimo Corporation in a research report on Thursday, August 3rd. Finally, BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $97.17.

Masimo Corporation Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.